TEVA - Teva Pharmaceutical reports mixed Q1 results; reaffirms FY24 outlook
2024-05-08 07:03:09 ET
More on Teva Pharmaceutical
- Teva Pharmaceutical Industries: Potential Outweighs Concerns
- Teva And Alvotech: Simlandi Approval Opens New Generic Market Opportunities
- Teva Pharmaceutical: I Need To See Top-Line Growth Return Before Starting A Position
- Novo, Teva, AstraZeneca issued FTC warnings over ‘bogus’ patents